[ad_1]
NEW YORK, Oct. 28, 2022 /PRNewswire/ — The “Marine Pharmaceuticals Market by Product and Geography – Forecast and Analysis 2022-2026” report has been added to Technavio’s offering. The market size is expected to grow by USD 1.56 billion between 2021 and 2026. In addition, the growth momentum is expected to accelerate at a CAGR of 7.73% during the forecast period, according to Techanavio’s latest market report estimates. This market study offers complete insights into the key revenue-generating segments, major growth regions, factors impacting the market size, and much more.
This report offers an up-to-date analysis regarding the latest trends and drivers, the current market scenario, and the overall market environment. Read our FREE PDF Sample Report
To help businesses improve their market position, the marine pharmaceuticals market provides a detailed analysis of around 25 vendors operating in the market. Some of these vendors include Amway Corp., BASF SE, BeyondSpring Inc., BioMarin Pharmaceutical Inc., Bristol Myers Squibb Co ., Eisai Co. Ltd., GlaxoSmithKline Plc, Guardian Industries Corp., Jazz Pharmaceuticals Plc, Koninklijke DSM NV, Merck KGaA, Nordic Naturals Inc., Pelagia EPAX, Pfizer Inc., Pharma Marine AS, PharmaMar SA, Seagen Inc., and Croda International Plc.
The report also covers the following areas:
- Marine Pharmaceuticals Market Size
- Marine Pharmaceuticals Market Trends
- Marine Pharmaceuticals Market Industry Analysis
Get lifetime access to our Technavio Insights. Subscribe now to our most popular “Basic Plan” billed annually at USD 5000. View 100 reports monthly and download 5 reports per month!
- Product
- Oncology
- Cardiovascular
- Anti-infectives
- Others
The oncology segment will be the largest contributor to market growth during the forecast period. Currently, the development of checkpoint inhibitors is gaining momentum. These are therapeutic antibodies that facilitate or enhance an immune response against tumor cells. Also, there are several drug candidates in clinical trials, which are expected to drive the growth of the market during the forecast period. In addition, the increasing availability and expansion of the indications by the US FDA are expected to drive the growth of the oncology segment of the global marine pharmaceuticals market during the forecast period.
- Geography
- North America
- Europe
- Asia
- Rest Of The World (ROW)
North America will account for 38% of the market’s growth during the forecast period. The growth of the regional market can be attributed to the high prevalence of various types of cancer and the increased availability of various marine pharmaceutical drugs for the treatment of different forms of carcinoma, pain, and CVD. The US and Canada are the key markets for marine pharmaceuticals in North America. Market growth in this region will be faster than the growth of the market in the Rest of the World (ROW).
Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report
- CAGR of the market during the forecast period 2022-2026
- Detailed information on factors that will assist marine pharmaceuticals market growth during the next five years
- Estimation of the marine pharmaceuticals market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the marine pharmaceuticals market
- Analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of marine pharmaceuticals market vendors
- Buy Report Now
Global Mono Vaccine Market 2022-2026: The global mono vaccine market is segmented by type (meningococcal vaccine, Japanese encephalitis vaccine, hepatitis vaccine, yellow fever vaccine, and others) and geography (North America, Europe, Asiaand the Rest of the World (ROW). The meningococcal vaccine segment will generate maximum revenue in the market. North America will account for a significant market share. View Report Snapshot Here
Global Nootropics Market 2022-2026: The global nootropics market is segmented by formulation (capsules, powder, drinks, and others) and geography (North America, Europe, Asiaand the Rest of the World (ROW). The capsules segment will generate maximum revenue in the market. North America will account for a significant market share. View Report Snapshot Here
|
Marine Pharmaceuticals Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2021 |
|
Forecast period |
2022-2026 |
|
| |
Full story available on Benzinga.com
[ad_2]
Source link
